Kodiak Sciences Inc. - 8-K Filing

Kodiak Sciences reports Q3 2026 net loss of $66.2 million and announces Zenkuda BLA submission planned for Q4 2026. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR · November 12, 2026, 21:00 UTC

Tickers: $KOD

Read the full article at SEC EDGAR

Part of the story TRANSCONTINENTAL REALTY INVESTORS INC - 8-K Filing (3 articles)

More Regulatory news

Ascend Wellness Holdings, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:10 UTC
ON SEMICONDUCTOR CORP - 8-K Filing SEC EDGAR · November 12, 2026, 21:10 UTC
Equillium, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:10 UTC
Exyn Technologies, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:10 UTC
Sanara MedTech Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:10 UTC
Invesco Galaxy Ethereum ETF - 8-K Filing SEC EDGAR · November 12, 2026, 21:10 UTC
PLIANT THERAPEUTICS, INC. - 10-Q Filing SEC EDGAR · November 12, 2026, 21:09 UTC
Arcadia Biosciences, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:09 UTC
US Foods Holding Corp. - 8-K Filing SEC EDGAR · November 12, 2026, 21:09 UTC
MARZETTI CO - 8-K Filing SEC EDGAR · November 12, 2026, 21:10 UTC